GIANSANTE, CARLO
 Distribuzione geografica
Continente #
NA - Nord America 6.642
EU - Europa 3.483
AS - Asia 2.600
SA - Sud America 242
AF - Africa 71
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 8
Totale 13.061
Nazione #
US - Stati Uniti d'America 6.552
IT - Italia 1.319
SG - Singapore 994
CN - Cina 708
SE - Svezia 420
UA - Ucraina 376
DE - Germania 337
VN - Vietnam 225
HK - Hong Kong 219
BR - Brasile 195
FR - Francia 177
GB - Regno Unito 171
FI - Finlandia 169
RU - Federazione Russa 153
KR - Corea 150
TR - Turchia 118
PL - Polonia 83
IE - Irlanda 64
BG - Bulgaria 62
IN - India 60
CA - Canada 54
NL - Olanda 44
BE - Belgio 26
MA - Marocco 20
MX - Messico 19
AR - Argentina 18
ES - Italia 18
JP - Giappone 18
SN - Senegal 18
AU - Australia 14
BD - Bangladesh 14
CH - Svizzera 13
IQ - Iraq 12
PK - Pakistan 11
ID - Indonesia 10
KE - Kenya 10
AT - Austria 9
TH - Thailandia 9
ZA - Sudafrica 9
EC - Ecuador 8
CZ - Repubblica Ceca 7
CO - Colombia 6
LT - Lituania 6
PH - Filippine 6
VE - Venezuela 6
EU - Europa 5
JO - Giordania 5
OM - Oman 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
CR - Costa Rica 4
DK - Danimarca 4
EG - Egitto 4
SA - Arabia Saudita 4
GR - Grecia 3
HR - Croazia 3
HU - Ungheria 3
PT - Portogallo 3
RO - Romania 3
SY - Repubblica araba siriana 3
TW - Taiwan 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CL - Cile 2
DO - Repubblica Dominicana 2
EE - Estonia 2
HN - Honduras 2
IL - Israele 2
KH - Cambogia 2
KW - Kuwait 2
MY - Malesia 2
NP - Nepal 2
PA - Panama 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
TG - Togo 2
TT - Trinidad e Tobago 2
UG - Uganda 2
UZ - Uzbekistan 2
AL - Albania 1
BB - Barbados 1
BW - Botswana 1
BZ - Belize 1
CM - Camerun 1
CU - Cuba 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GI - Gibilterra 1
GT - Guatemala 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
PE - Perù 1
PW - Palau 1
Totale 13.055
Città #
Woodbridge 867
Ann Arbor 699
Fairfield 585
Ashburn 570
Singapore 560
Houston 503
Chandler 428
Jacksonville 336
Wilmington 274
San Jose 269
Seattle 256
Hong Kong 213
Cambridge 208
Hefei 162
Beijing 159
Seoul 147
Princeton 122
Milan 115
Boardman 105
Izmir 101
Dearborn 91
Chicago 82
Rome 72
Trieste 72
Los Angeles 71
Ho Chi Minh City 69
Dublin 64
Lauterbourg 62
Sofia 62
Moscow 59
Zgierz 58
Columbus 55
Hanoi 55
Santa Clara 51
Buffalo 49
The Dalles 49
Helsinki 42
Munich 41
Düsseldorf 31
Dallas 30
Verona 29
San Diego 28
Turin 28
Frankfurt am Main 26
Brussels 25
Naples 24
Kunming 23
Nanjing 23
Bari 22
London 22
Ottawa 22
Bologna 21
Council Bluffs 19
Warsaw 19
Dakar 18
Florence 18
Venezia 18
Casablanca 17
Grafing 17
Shanghai 17
New York 16
Tokyo 16
Turku 16
Venice 16
Des Moines 15
Guangzhou 15
Orem 15
São Paulo 15
Bremen 14
Haiphong 14
Mestre 14
Redondo Beach 14
Atlanta 13
Cagliari 13
Montreal 13
Phoenix 13
Chennai 12
Jinan 12
Redwood City 12
Shenyang 12
Tianjin 12
Pune 11
Washington 11
Auburn Hills 10
Da Nang 10
Falls Church 10
Hangzhou 10
Nuremberg 10
Catania 9
Denver 9
Nairobi 9
Sydney 9
Zhengzhou 9
Changsha 8
Grugliasco 8
Miano 8
Modena 8
Norwalk 8
Palermo 8
Sacile 8
Totale 8.745
Nome #
Continuità assistenziale ospedale-territorio per il paziente con scompenso cardiaco cronico: Una rivoluzione e una sfida nella cura ambulatoriale 1.151
Derivation and Validation of a Biomarker-Based Clinical Algorithm to Rule Out Sepsis From Noninfectious Systemic Inflammatory Response Syndrome at Emergency Department Admission: A Multicenter Prospective Study 382
Body composition and muscular strength changes after moderate activity: association with matrix metalloproteinase polymorphisms. 305
Carotid plaque vulnerability and matrix metalloproteinase -1 and -9 genetic polymorphisms 294
Oral anticoagulation and VKORC1 polymorphism in patients with a mechanical heart prosthesis: a 6-year follow-up 293
Coagulation indicators in patients with paroxysmal atrial fibrillation: Effects of electric and pharmacologic cardioversion. 285
Serum Response Factor depletion affects the proliferation of the hepatocellular carcinoma cells HepG2 and JHH6 281
D-dimer and anticoagulation in patients with mechanical prosthetic heart valves. A 2-year follow-up. 276
Current strategies to improve the efficacy and the delivery of nucleic acid based drugs 267
Features of vulnerable plaques and clinical outcome of UA/NSTEMI: Relationship with matrix metalloproteinase finctional polymorphisms. 254
Characterization of nucleic acid molecule/liposome complexes and rheological effects on pluronic/alginate matrices 253
Alcohol reduces MMP-2 in humans and isolated smooth muscle cells. 244
Remodeling in acute coronary syndromes: expectations and frustrations for risk assessment and therapy. 240
Age as a Risk Factor for Stroke in Atrial Fibrillation Patients 239
Effects of E2F1-cyclinE1-E2 circuit down-regulation in hepatocellular carcinoma cells 232
Aptamers as nano-targeting delivery devices or anti-cancer drugs for fighting tumours 229
Dissecting the expression of EEF1A1/A2 genes in human prostate cancer cells: the potential od EEF1A2 as a hallmark for prostate transformation and progression 227
MMP-9 microsatellite polymorphism: association with the progression of intima-media thickening and constrictive remodeling of carotid atherosclerotic plaques. 225
Mechanisms of malnutrition in uremia. 212
Insights into human hypertension: the role of endothelial dysfunction. 210
Disseminated tuberculosis in an immunocompetent patient 209
Coagulation indicators in chronic stable effort angina and unstable angina: relationship with acute phase reactants and clinical outcome. 204
Plasma concentrations of interleukin-2 soluble receptor in mild ischaemic left ventricular dysfunction. 200
Control of anticoagulant therapy with portable prothrombin time device in patients with mechanical heart valve prostheses: two-year follow-up 195
Platelet function and clotting parameters of vibration-exposed foundry workers. 195
Regulation of energy balance and blood pressure: are genetic polymorphisms pertinent? 192
MMP-9 microsatellite polymorphism and susceptibility to exudative form of age-related macular degeneration. 190
Calciphylaxis of the breast: a rare disease in the differential diagnosis of breast cancer 188
MMP-9 microsatellite polymorphism and multiple sclerosis. 187
Cyclin E1, E2 and E2F1 targeted siRNAs down regulate the growth of coronary smooth muscle cell, thus showing their potential use in the prevention of in-stent restenosis 185
In-hospital outcome of patients with acute coronary syndrome: relationship with inflammation and remodeling markers. 181
MMP-9 microsatellite polymorphism and susceptibility to carotid arteries atherosclerosis. 180
Improving siRNA Bio-Distribution and Minimizing Side Effects 180
Genetic approaches to hypertension: relevance to human hypertension 175
Inborn prothrombotic states 175
Monitoring of hemostasis 172
[Ximelagatran: a promising new drug for oral anticoagulation] 171
Aptamers as targeting delivery devices or anti-cancer drugs for fighting tumors 171
Proliferation of human primary vascular smooth muscle cells depends on serum response factor. 166
The Integration of qSOFA with Clinical Variables and Serum Biomarkers Improves the Prognostic Value of qSOFA Alone in Patients with Suspected or Confirmed Sepsis at ED Admission 166
Heterogeneous models for an early discrimination between sepsis and non-infective SIRS in medical ward patients: a pilot study 157
[Disease management system in patients with chronic heart failure] 156
Metalloproteinases-2, -9 and TIMP-1 expression in stable and unstable coronary plaques undergoing PCI. 155
Relation of haemostatic function, neurovascular impairment, and vibration exposure in workers with different stages of vibration induced white finger 155
Long term prognosis in patients with peripheral arterial disease treated with antiplatelet agents. 151
null 150
MMP-2 genetic variant and plaque features of instability 149
null 148
Evaluation of principal risk factors, hemorheological and blood coagulation characteristics in arteriosclerosis obliterans in the elderly 147
Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease. 147
null 146
Treatment of intermittent claudication with antiplatelet agents. 138
Psoriasis and endothelins. 135
Effects of various promoter derived sequences on the cleavage kinetic of an hammerhead ribozyme directed against cyclin E1 mRNA. 135
Risk factors associated with early central nervous system damage detected through Diffusion Tensor Imaging (DTI) in patients with Systemic Lupus Erythematosus 132
Evaluation of bortezomib impact on cell-cycle related genes in the hepatocellular carcinoma cell lines hepg2 and jhh6 by means of microarray analysis 127
Genetic Variants of Matrix Metalloproteinase and Sepsis: The Need Speed Study 126
null 121
Role of E2F1–Cyclin E1-Cyclin E2 Circuit in Human Coronary Smooth Muscle Cell Proliferation and Therapeutic Potential of Its Downregulation by siRNAs 121
Interleukin-1 receptor antagonist: a sensitive marker of instability in patients with coronary artery disease. 117
Inhibitory effects of fenofibrate on apoptosis and cell proliferation in human endothelial cells in high glucose 104
Intravenous pentoxifylline in Fontaine stage II and III peripheral arterial diseases 103
New perspectives for anticoagulation in non-rheumatic atrial fibrillation: oral antithrombins 96
null 96
Short term effects of doxycycline on matrix metalloproteinases 2 and 9. 81
null 73
Prostate Tumour-Inducing gene-1 analysis in human prostate cancer cells and tissue in relation to Mycoplasma infection 65
[Clinical practice: Ebstein's anomaly] 1
Totale 13.213
Categoria #
all - tutte 34.160
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.160


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021276 0 0 0 0 0 0 0 0 0 125 55 96
2021/2022924 40 62 43 129 31 94 28 45 109 102 75 166
2022/20231.350 120 134 114 192 148 220 44 108 160 19 61 30
2023/2024798 61 65 44 56 97 73 84 119 19 42 71 67
2024/20251.496 34 47 85 132 188 148 107 94 203 177 119 162
2025/20262.961 332 191 226 310 267 324 460 77 351 423 0 0
Totale 13.213